Horizon Technology Finance Corporation 6.25% Notes due 2027
HTFCDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 30, 2026 | $0.39 | 2026-06-15 | 2026-06-15 |
| March 30, 2026 | $0.39 | 2026-03-13 | 2026-03-13 |
| December 30, 2025 | $0.39 | 2025-12-15 | 2025-12-15 |
| September 30, 2025 | $0.39 | 2025-09-15 | 2025-09-15 |
| June 30, 2025 | $0.39 | 2025-06-13 | 2025-06-13 |
Dividends Summary
- Consistent Payer: Horizon Technology Finance Corporation 6.25% Notes due 2027 has rewarded shareholders with 16 dividend payments over the past 4 years.
- Total Returned Value: Investors who held HTFC shares during this period received a total of $6.32 per share in dividend income.
- Latest Payout: The most recent dividend of $0.39/share was paid 18 days ago, on June 30, 2026.
- Yield & Schedule: HTFC currently pays dividends quarterly with an annual yield of 6.27%.
- Dividend Growth: Since 2022, the dividend payout has decreased by 15.1%, from $0.46 to $0.39.
Company News
Monroe Capital Corporation (MRCC) announced a final distribution of $0.60 per share ($13.0 million total) contingent on closing its asset sale to Monroe Capital Income Plus Corporation and merger with Horizon Technology Finance Corporation (HRZN). The distribution is expected to be paid on April 17, 2026, sourced from net proceeds of the asset sa...
Monroe Capital Corporation (MRCC) announced a final cash distribution to stockholders ahead of its merger with Horizon Technology Finance Corporation (HRZN). The distribution will include all undistributed net ordinary income and capital gains through the merger closing, plus $13.0 million from asset sale proceeds. The merger is expected to close...
Johnson Fistel, PLLP announced investigations into potential securities law violations by Green Dot Corporation, Lifecore Biomedical, and Horizon Technology Finance on behalf of affected investors. Green Dot's stock declined approximately 7% following the company's announcement of delayed financial results for Q4 and full year 2025.
Johnson Fistel, PLLP announced investigations into three companies on March 16, 2026. Lifecore Biomedical issued disappointing 2026 revenue guidance of $120-125 million versus $141.4 million in 2025, citing customer loss and product launch delays, resulting in an 18% stock decline. The firm is also investigating Horizon Technology Finance and G-I...
Johnson Fistel, PLLC is investigating potential securities fraud claims on behalf of investors in Horizon Technology Finance Corporation and other companies. Horizon Technology Finance's stock fell approximately 23% following the announcement of lower-than-expected net investment income for Q4 2025, prompting the investigation into potential fede...
